Evidence map›Paper›PMID 41403676›Full record

ReviewRSC advances2025

Zinc selenide engineered nanostructures: insights into modification strategies, and multifunctional applications in environmental remediation, gas sensing, energy storage, and antimicrobial activity.

Ruhit Kumar Paul, Saptarshi Roy, Md Ahmaruzzaman

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ruhit Kumar PaulDepartment of Chemistry, National Institute of Technology Silchar 788010 Assam India mda2002@gmail.com.
Saptarshi RoyDepartment of Chemistry, National Institute of Technology Silchar 788010 Assam India mda2002@gmail.com.
Md AhmaruzzamanDepartment of Chemistry, National Institute of Technology Silchar 788010 Assam India mda2002@gmail.com.ORCID https://orcid.org/0000-0002-6805-5409

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc selenide (ZnSe), an outstanding and admirable photocatalytic material from the II-VI group, exhibits a direct energy band gap of 2.67 eV. This rising contender has sparked considerable attention owing to its distinctive physicochemical characteristics and extensive multifunctional potential. This article commences with a comprehensive and systematic exploration of the intrinsic novel attributes of ZnSe nanostructures, encompassing their structural, optical, and electronic novelties. It further summarizes the various fabrication methodologies which have been instrumental in tailoring parameters like particle size, morphology, and crystallinity to optimize functional performance across a breadth of applications. Key modification strategies, including elemental doping and heterojunction engineering, are highlighted to underscore their indispensable roles in mitigating the recombination rate while enhancing the efficiency of photoinduced charge carrier separation and migration. The discourse progresses to delineate the evolution from conventional composite architectures to advanced Z-scheme configurations, offering profound insights into their revolutionary implications. Additionally, essential characterization techniques are surveyed, elucidating the intricate correlations between structural, morphological, optical, and electronic properties and their resultant influence on functional efficacy. Furthermore, the study spotlights the recent advancements in multifaceted applications in utilizing ZnSe-based composites as potential tools for environmental applications, including the removal of hazardous heavy metals, pharmaceuticals, phenolic compounds, and other persistent organic contaminants, as well as their role in CO

Identifiers

PMID41403676
PMCPMC12704589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.